These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31107831)

  • 1. Addressing clozapine under-prescribing and barriers to initiation: a psychiatrist, advanced practice provider, and trainee survey.
    Leung JG; Cusimano J; Gannon JM; Milgrom O; Valcourt SC; Stoklosa JB; Kemp M; Olsufka W; Vickery PB; Nichols SD; Crouse EL; Paxos C; Johnson EK; Palmer BA
    Int Clin Psychopharmacol; 2019 Sep; 34(5):247-256. PubMed ID: 31107831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatrists' attitude towards the use of clozapine in the treatment of refractory schizophrenia: A nationwide survey.
    Daod E; Krivoy A; Shoval G; Zubedat S; Lally J; Vadas L; Weizman A; Reshef A; Bloch B
    Psychiatry Res; 2019 May; 275():155-161. PubMed ID: 30913436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comfort Level and Barriers to the Appropriate Use of Clozapine: a Preliminary Survey of US Psychiatric Residents.
    Singh B; Hughes AJ; Roerig JL
    Acad Psychiatry; 2020 Feb; 44(1):53-58. PubMed ID: 31713078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatrists' attitude towards and knowledge of clozapine treatment.
    Nielsen J; Dahm M; Lublin H; Taylor D
    J Psychopharmacol; 2010 Jul; 24(7):965-71. PubMed ID: 19164499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing of Clozapine and Antipsychotic Polypharmacy for Schizophrenia in a Large Medicaid Program.
    Tang Y; Horvitz-Lennon M; Gellad WF; Lave JR; Chang CH; Normand SL; Donohue JM
    Psychiatr Serv; 2017 Jun; 68(6):579-586. PubMed ID: 28196460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescriber and institutional barriers and facilitators of clozapine use: A systematic review.
    Verdoux H; Quiles C; Bachmann CJ; Siskind D
    Schizophr Res; 2018 Nov; 201():10-19. PubMed ID: 29880453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine: a review of clinical practice guidelines and prescribing trends.
    Warnez S; Alessi-Severini S
    BMC Psychiatry; 2014 Apr; 14():102. PubMed ID: 24708834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iranian psychiatrists' attitude towards clozapine use for patients with treatment-resistant schizophrenia: a nationwide survey.
    Rezaie L; Nazari A; Safari-Faramani R; Shohaimi S; Khazaie H
    BMC Psychiatry; 2022 Aug; 22(1):534. PubMed ID: 35933353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practitioner attitudes to clozapine initiation.
    Gee S; Vergunst F; Howes O; Taylor D
    Acta Psychiatr Scand; 2014 Jul; 130(1):16-24. PubMed ID: 24004162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between physicians' and nurse practitioners' viewpoints on reasons for clozapine underprescription.
    Okhuijsen-Pfeifer C; Cohen D; Bogers JPAM; de Vos CMH; Huijsman EAH; Kahn RS; Luykx JJ
    Brain Behav; 2019 Jul; 9(7):e01318. PubMed ID: 31144470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing and monitoring clozapine in Christchurch.
    McKean A; Vella-Brincat J; Begg E
    Australas Psychiatry; 2008 Aug; 16(4):263-7. PubMed ID: 18668375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood Draw Barriers for Treatment with Clozapine and Development of a Point-of-Care Monitoring Device.
    Kelly DL; Ben-Yoav H; Payne GF; Winkler TE; Chocron SE; Kim E; Kitchen C; Stock V; Vyas G; Love RC; Wehring HJ; Sullivan KM; Feldman S; Liu F; McMahon RP; Ghodssi R
    Clin Schizophr Relat Psychoses; 2018; 12(1):23-30. PubMed ID: 26218235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparison of Attitudes, Comfort, and Knowledge of Clozapine Among Two Diverse Samples of US Psychiatrists.
    Cotes RO; Janjua AU; Broussard B; Lazris D; Khan A; Jiao Y; Kopelovich SL; Goldsmith DR
    Community Ment Health J; 2022 Apr; 58(3):517-525. PubMed ID: 34052963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine prescribing barriers in the management of treatment-resistant schizophrenia: A systematic review.
    Baig AI; Bazargan-Hejazi S; Ebrahim G; Rodriguez-Lara J
    Medicine (Baltimore); 2021 Nov; 100(45):e27694. PubMed ID: 34766570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnic comparisons of antipsychotic use in schizophrenia.
    Wheeler A; Humberstone V; Robinson E
    Aust N Z J Psychiatry; 2008 Oct; 42(10):863-73. PubMed ID: 18777230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How and when to use clozapine.
    Rubio JM; Kane JM
    Acta Psychiatr Scand; 2020 Mar; 141(3):178-189. PubMed ID: 31603988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of audit and feedback on antipsychotic prescribing in schizophrenia.
    Wheeler A; Humberstone V; Robinson E; Sheridan J; Joyce P
    J Eval Clin Pract; 2009 Jun; 15(3):441-50. PubMed ID: 19366393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clozapine use in Maryland and in Victoria, Australia.
    Conley RR; Kelly DL; Lambert TJ; Love RC
    Psychiatr Serv; 2005 Mar; 56(3):320-3. PubMed ID: 15746507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine Underutilization in the Treatment of Schizophrenia: How Can Clozapine Prescription Rates Be Improved?
    Bogers JP; Schulte PF; Van Dijk D; Bakker B; Cohen D
    J Clin Psychopharmacol; 2016 Apr; 36(2):109-11. PubMed ID: 26872120
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences between counties in the prescribing of clozapine.
    Schou MB; Drange OK; Sæther SG
    Tidsskr Nor Laegeforen; 2019 Sep; 139(13):. PubMed ID: 31556524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.